SWAD: Large-Area Photon Counting X-Ray Imager using Amorphous Selenium
Project Number7R01EB026644-05
Contact PI/Project LeaderGOLDAN, AMIRHOSSEIN
Awardee OrganizationWEILL MEDICAL COLL OF CORNELL UNIV
Description
Abstract Text
Abstract
The field of medical x-ray imaging experienced a "digital revolution" in the early 2000s, with the
spreading of digital radiography systems which are based on active matrix at panel imagers (AMFPI).
Since then we have seen rapid development and clinical translation of large-area AMFPI based on amorphous silicon active matrix technology. However they have one major difficulty to overcome: producing
x-ray quantum noise limited images at very low dose. Advanced applications of AMFPI, including tomosynthesis and cone-beam computed tomography have fueled the development of the next generation
detectors, mainly in the ability of AMFPI to generate high quality images that are quantum noise limited
and free from artifacts at low x-ray exposures and high frame rates. An alternative approach is to operate
the detector in pulse mode for photon counting which provides higher dose efficiency through efficient
noise rejection, quantum-noise limited performance, and optimal energy weighting. Photon counting
systems are also not susceptible to memory artifacts. While the development of photon counting detector for computed tomography has been very promising, no commercial photon counting 2D sensors
exists for radiography or mammography due to the simultaneous requirement for both high resolution
and large area. Our hypothesis is that a direct-conversion amorphous selenium detector with unipolar
time-differential (UTD) charge sensing and avalanche gain can yield a cost-effective and large-area photon
counting imager with spectroscopic capabilities. The true impact of photon counting is to provide hyperspectral imaging (via multi-energy thresholding) to enable widespread application of contrast enhanced
(CE) breast imaging with rapid acquisition and without motion artifacts (via simultaneous acquisition of
high energy and low images during a single x-ray exposure). The objective of this proposal is therefore
to fabricate and test a prototype photon counting imager using the proposed eld-Shaping multi-Well
Avalanche Detector (SWAD). Conceptually the proposed SWAD imager employs four major components:
(1) a photon counting chip, (2) multi-well pixel geometry, (3) amorphous selenium (a-Se) photoconductor
deposited over the multi-well substrate for UTD charge sensing and avalanche gain, and finally (4) an
image acquisition circuit board where the SWAD chip will be connected to. We expect to show that the
proposed photon counting SWAD imager has quantum-noise-limited performance, high spectral sensitivity for energy weighting, and high frame-rates. Successful development of SWAD will lead to the first ever
cost-effective and large-area photon counting detector for x-ray imaging. Although this is seemingly a
high cost proposal, the technological innovation we develop will lead to the widespread clinical application
of a more efficient and lower dose contrast-enhanced cancer screening system for mammography.
Public Health Relevance Statement
Narratives/Relevance
In the proposed work we will develop a prototype hyperspectral photon counting imager
using the field-Shaping multi-Well Avalanche Detector (SWAD) for high spatial resolution
contrast-enhanced x-ray breast imaging. Given that the photosensor material is amorphous,
the detector structure is inherently inexpensive, and thus, it enables a cost-effective imager
design with large area scalability. Also, the photon counting imager will permit quantum-
noise-limited performance, energy weighting, high frame-rates, and multi-energy thresholding. Although this is seemingly a high cost proposal, the technological innovation we develop
will lead to the widespread clinical application of a more efficient and lower dose contrast-
enhanced cancer screening system for mammography.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
060217502
UEI
YNT8TCJH8FQ8
Project Start Date
01-July-2019
Project End Date
31-May-2025
Budget Start Date
01-June-2023
Budget End Date
31-May-2025
Project Funding Information for 2022
Total Funding
$248,193
Direct Costs
$160,000
Indirect Costs
$88,193
Year
Funding IC
FY Total Cost by IC
2022
National Institute of Biomedical Imaging and Bioengineering
$248,193
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R01EB026644-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R01EB026644-05
Patents
No Patents information available for 7R01EB026644-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R01EB026644-05
Clinical Studies
No Clinical Studies information available for 7R01EB026644-05
News and More
Related News Releases
No news release information available for 7R01EB026644-05
History
No Historical information available for 7R01EB026644-05
Similar Projects
No Similar Projects information available for 7R01EB026644-05